# Study of NK Combined With Chemotherapy for Advanced Solid Tumor

> **NCT04214730** · NA · UNKNOWN · sponsor: **Yantai Yuhuangding Hospital** · enrollment: 60 (estimated)

## Conditions studied

- Solid Tumor

## Interventions

- **COMBINATION_PRODUCT:** NK combined with Chemotherapy
- **DRUG:** Chemotherapy

## Key facts

- **NCT ID:** NCT04214730
- **Lead sponsor:** Yantai Yuhuangding Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-12-31
- **Primary completion:** 2023-12
- **Final completion:** 2023-12
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2023-03-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04214730

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04214730, "Study of NK Combined With Chemotherapy for Advanced Solid Tumor". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04214730. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*